Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 10:45 AM ESTCompany ParticipantsChristopher Young - ...
Abstract: Weighted vertex cover (WVC) problem, as one of the most important combinatorial optimization problems, is a general form of the classic vertex cover problem. The existing researches focused ...
The X logo appears on a smartphone screen. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images) (NurPhoto via Getty Images) When X's engineering team published the code that powers the platform's ...
In 2023, the website then known as Twitter partially open sourced its algorithm for the first time. In those days, Tesla billionaire Elon Musk had only recently acquired the platform, and he claimed ...
Graph cover problems form a critical area within discrete optimisation and theoretical computer science, addressing the challenge of selecting subsets of vertices (or edges) that satisfy predetermined ...
This strengthens Google’s position against rivals such as Microsoft and AWS as enterprises seek faster, more reliable ways to deploy and manage AI agents. Google Cloud has updated its Vertex AI Agent ...
Abstract: 3-path vertex cover of networks is a typical optimization problem in network science, which has a wide range of applications. Toward a 3-path vertex cover of networks from distributed ...
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported better-than-expected earnings for the second quarter after the market close on Monday. The company's revenue came in at $2.97 billion versus estimates ...
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based Big Biotech’s sodium channel inhibitor VX-993 failed to outpace ...
Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...
CHONGQING, CHINA - JULY 30: In this photo illustration, a smartphone displays the logo of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), a global biotechnology company focused on developing therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results